Skip to main content
Wellcome Sanger Institute
Careers | Find us | Contact us
  • About
    • Our Vision
    • Leadership
    • Strategy and Funding
    • Influencing Policy
    • Equality in Science
    • Careers
    • Study
    • Research Policies
    • Campus Connections
    • Admin Groups
    • Branding and Logos
  • Science
    • COVID-19 Research
    • Programmes
    • Scientific Groups
    • Collaborations
    • Tools
    • Data
    • Sanger Projects
    • Publications
    • Sanger Seminar Series
  • People
    • Leadership
    • Faculty
    • Associate Faculty
    • Honorary Faculty
    • International Fellows
    • Science Staff
    • Non-science Staff
    • Full A-Z
  • Innovation
    • Innovation at the Institute
    • For Industry
    • For Researchers
    • Case Studies
    • Our Spin-Outs
    • Sanger Technologies
  • News
Wellcome Sanger Institute

Innovation

We seek to deliver therapeutic, diagnostic and production benefits in areas as diverse as cancer, immunology, public health and personalised treatment.

Innovation at the Sanger Institute
Sanger Technologies
For Industry
Case Studies
Spin-outs
For Researchers

CASE STUDIES

1. Commercialising a database

The advancing genomic revolution was increasing the rate of cancer mutational data available in 2013 and at the same time, the cancer research community needed an accurate centralised database to aggregate and interrogate data. We needed to protect, organise and curate this precious data. Our solution was to commercialise the COSMIC database.

 

2. The global fight against malaria

Despite much progress that has been made to battle malaria, it remains a significant global healthcare challenge. Sanger’s researchers work towards the application of Sanger’s science in a number of areas such as drug discovery, vaccine discovery, epidemiological surveillance, diagnostics and precision medicine. This case study describes three ambitious Sanger projects focused on battling malaria.

For Industry

We create technologies and therapies of tomorrow through open dialogue with our commercial partners. Get in touch with any member of our business development team today to discuss partnering

Find out more

For Researchers

We use our expertise in all aspects of technology identification, assessment, IP protection, development and commercialisation, to help you develop your research into a product or service that creates healthcare benefit

Find out more

Spin-Outs

Spin-outs

We’ve supported the creation of four spin-out companies to date; to learn more about Congenica, Kymab, Microbiotica and VHSquared

Find out more

Licenses

Licences

Licensing is one way we disseminate knowledge and resources to benefit the scientific community and improve healthcare

Find out more

Collaborations

Collaborations

Strategic partnerships marry the formidable science base of the Institute with the capabilities of commercial partners to add value to our technologies

Find out more

Sanger Technologies

We create technologies and therapies of tomorrow through open dialogue with our many partners. For a list of all current partnership opportunities that fall into either one or more than one of these types-software, data, biological tools or kits; browse the Sanger Technologies page and get in touch today.

Wellcome Sanger Institute
Sanger Logo

Wellcome Genome Campus,
Hinxton, Cambridgeshire,
CB10 1SA. UK
+44 (0)1223 834244

  • About
  • Legal
  • Data sharing
  • Careers
  • Privacy
  • Equality, Diversity, Inclusion
  • Study
  • Cookies
  • Modern Slavery Statement
ROSPA Gold
Athena Swan

Expand footer

Wellcome Sanger Institute, Genome Research Limited (reg no. 2742969) is a charity registered in England with number 1021457

2021 Wellcome Sanger Institute | All rights reserved